Indeed, CRISPR-Cas9-mediated deletion of PHF6 in a murine BCR-ABL1+; p19-/-; mCherry+ B-ALL cell line resulted in delayed tumor formation after injection in immunocompetent mice compared to wild-type B-ALL cells (69). The gene discussed is PHF6; the disease is acute lymphoblastic leukemia.